Skip to main content

Placental Insufficiency

by Lucija Buric

The placenta is a vital organ that ensures the transfer of oxygen and nutrients from the mother to the fetus while also removing waste products. However, when this process is impaired, it leads to placental insufficiency, a condition that affects 1 in 3 pregnancies and contributes significantly to complications such as intrauterine growth restriction (IUGR), preeclampsia, and even miscarriage. In fact, 15–20% of miscarriages are linked to placental insufficiency, making it a critical concern in maternal-fetal medicine.

Understanding Placental Insufficiency

Several factors contribute to placental insufficiency, including maternal age, genetic influences, and environmental conditions. Maternal age plays a crucial role, with miscarriage rates increasing from about 10% in women in their 20s to over 50% by age 45. Additionally, maternal lifestyle choices—such as smoking, alcohol and drug use, and pre-existing conditions like diabetes and heart disease—further elevate the risk.

Interestingly, placental disorders have been documented since ancient times, dating back to Egyptian and Greek medical texts. However, rather than being solely a result of modern lifestyle factors, their prevalence today may reflect evolutionary adaptations in human reproduction and development. This perspective offers new insights into why certain populations, particularly those with limited healthcare access, experience higher risks of placental insufficiency.

Evolutionary Insights into Placental Health

Pregnancy complications vary across species due to placental diversity. The human placenta is uniquely highly invasive, a feature believed to be driven by the brain’s substantial energy demands. Compared to other mammals, human trophoblast invasion is significantly more aggressive, ensuring the fetus receives the nutrients required for its development.

One fascinating hypothesis suggests that placental invasion results from maternal-fetal conflict, sometimes referred to as an “arms race” between mother and fetus. Younger mothers might allocate fewer resources to their first pregnancy to preserve future reproductive potential, while older mothers may invest more in their current fetus. However, this contrasts with the increased pregnancy risks observed in older women, adding complexity to this evolutionary debate.

Another theory, the grandmother hypothesis, proposes that older mothers conserve energy to assist in raising their grandchildren rather than investing heavily in their own late pregnancies. This idea challenges the concept of maternal-fetal conflict and suggests that human reproductive strategies may have evolved to optimize survival across generations.

Placenta protects and allows baby to have healthy environment.

The Role of Environmental Mismatch

Rapid environmental changes, including shifts in diet, toxin exposure, and healthcare accessibility, contribute to placental insufficiency. The placenta evolved as an adaptive organ that responds to both the internal genetic makeup of the fetus and external environmental factors. When these factors are mismatched—such as modern diets differing drastically from those of our ancestors—placental function can be disrupted, increasing pregnancy complications.

Genetic influences also play a role, with factors like chromosomal trisomies, imprinting errors, and viral RNA insertions affecting placental health. These genetic conflicts, combined with changing environmental conditions, may partly explain the rise in placental disorders today.

Advancing Placental Health

With growing knowledge of genetic and epigenetic influences on placentation, future treatments may focus on gene-editing technologies like CRISPR-Cas9 to correct genetic errors associated with placental insufficiency. Additionally, epigenetic therapies could help modulate placental function and reduce pregnancy risks for high-risk mothers.

The development of nanomedicine offers another promising avenue, with targeted drug delivery systems designed to enhance placental function. These advances may also improve the success of in vitro fertilization (IVF) by optimizing early placental development.

Looking even further ahead, artificial womb technologies could revolutionize maternal-fetal care, particularly for extremely premature infants. By mimicking placental function, these innovations may one day provide tailored support for pregnancies affected by placental insufficiency.

Conclusion

Placental insufficiency is a complex condition with deep evolutionary roots. By examining its causes through both historical and genetic lenses, we can develop more effective treatments and improve pregnancy outcomes. As research continues to uncover the intricate relationship between the placenta, the mother, and the environment, we move closer to a future where maternal and fetal health is better understood and supported with cutting-edge medical advancements.

References

  • Chuong, E. B., Hannibal, R. L., Green, S. L., & Baker, J. C. (2013). Evolutionary perspectives into placental biology and disease. Applied & Translational Genomics, 2, 64–69. https://doi.org/10.1016/j.atg.2013.07.001
  • Huang, Z., Xiao, T., & Zhou, W. (2023). Artificial womb: A paradigm shift for saving extremely premature infants. Chinese Medical Journal, 136(14), 1759–1761. https://doi.org/10.1097/cm9.0000000000002745
  • Jauniaux, E., Poston, L., & Burton, G. J. (2006). Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Human Reproduction Update, 12(6), 747–755. https://doi.org/10.1093/humupd/dml016
  • Khan, F. A., Pandupuspitasari, N. S., ChunJie, H., Ahmad, H. I., Wang, K., Ahmad, M. J., & Zhang, S. (2018). Applications of CRISPR/Cas9 in reproductive biology. Current Issues in Molecular Biology, 26(1), 93-102. https://doi.org/10.21775/cimb.026.093
  • van Kammen, R., van Woudenberg, F., Schiffelers, R., Terstappen, L., & Lely, A. T. (2023). Nanomedicines: An approach to treat placental insufficiency and the current challenges. Journal of Controlled Release, 360, 57–68. https://doi.org/10.1016/j.jconrel.2023.06.003
  • Wang, L. Q., Fernandez-Boyano, I., & Robinson, W. P. (2022). Genetic variation in placental insufficiency: What have we learned over time? Frontiers in Cell and Developmental Biology, 10. https://doi.org/10.3389/fcell.2022.1038358
  • Simoncic, V., Deguen, S., Enaux, C., Vandentorren, S., & Kihal-Talantikite, W. (2022). A comprehensive review on social inequalities and pregnancy outcomes—Identification of relevant pathways and mechanisms. International Journal of Environmental Research and Public Health, 19(24), 16592. https://doi.org/10.3390/ijerph192416592
  • Wardinger, J. E., & Ambati, S. (2021). Placental insufficiency. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK563171/